Silver-doped calcium phosphate nanoparticles: Synthesis, characterization, and toxic effects toward mammalian and prokaryotic cells

Colloids and Surfaces B: Biointerfaces

Volumn 102, Issue , 2013, Pages 724-729

  Peetsch, Alexander ^a   Greulich, Christina ^b   Braun, Dieter ^a   Stroetges, Christian ^c   Rehage, Heinz ^c   Siebers, Bettina ^a   Köller, Manfred ^b   Epple, Matthias ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c TU DORTMUND UNIVERSITY   (Germany)

Author keywords

Bacteria; Calcium phosphate; Human mesenchymal stem cells; Nanoparticles; Peripheral blood mononuclear cells; Silver

Indexed keywords

CALCIUM NITRATE; CALCIUM PHOSPHATE NANOPARTICLES; CARBOXY-METHYL CELLULOSE; CONTINUOUS PROCESS; ESCHERICHIA COLI (E. COLI); HUMAN MESENCHYMAL STEM CELLS; MAMMALIAN CELLS; MONONUCLEAR CELLS; PERIPHERAL BLOOD MONONUCLEAR CELLS; PROKARYOTIC CELLS; S. AUREUS; SILVER ACETATE; SILVER CONCENTRATION; SILVER CONTENT; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES; TOXIC EFFECT;

AMMONIUM COMPOUNDS; BACTERIA; CALCIUM PHOSPHATE; CYTOLOGY; ESCHERICHIA COLI; INDUSTRIAL POISONS; MAMMALS; NANOPARTICLES; PRECIPITATION (CHEMICAL); STEM CELLS; SYNTHESIS (CHEMICAL);

SILVER;

ACETATE SILVER; AMMONIUM PHOSPHATE; CALCIUM NITRATE; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE NANOPARTICLE; CARBOXYMETHYLCELLULOSE; INORGANIC SALT; NANOPARTICLE; SILVER; SILVER DERIVATIVE; SILVER NITRATE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CELL VIABILITY; CHEMICAL MODIFICATION; COLLOID; CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MAMMAL CELL; MESENCHYMAL STEM CELL; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHARMACOLOGICAL PARAMETERS; PRECIPITATION; PRIORITY JOURNAL; PROKARYOTIC CELL; STAPHYLOCOCCUS AUREUS; SYNTHESIS; THERMOGRAVIMETRY;

ANTI-BACTERIAL AGENTS; CALCIUM PHOSPHATES; CELL LINE; CELL SURVIVAL; ESCHERICHIA COLI; HUMANS; LEUKOCYTES, MONONUCLEAR; METAL NANOPARTICLES; SILVER; STAPHYLOCOCCUS AUREUS;

ESCHERICHIA COLI; MAMMALIA; PROKARYOTA; STAPHYLOCOCCUS AUREUS;

EID: 84867813427     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.09.040     Document Type: Article

References (54)

1. Hidron A.I., Edwards J.R., Patel J., Horan T.C., Sievert D.M., Pollock D.A., Fridkin S.K. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 2008, 29:996-1011.
2. Harris S.R., Feil E.J., Holden M.G., Quail M.A., Nickerson E.K., Chantratita N., Gardete S., Tavares A., Day N., Lindsay J.A., Edgeworth J.D., de Lencastre H., Parkhill J., Peacock S.J., Bentley S.D. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010, 327:469-474.
3. Giske C.G., Monnet D.L., Cars O., Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob. Agents Chemother. 2008, 52:813-821.
4. Fischbach M.A., Walsh C.T. Antibiotics for emerging pathogens. Science 2009, 325:1089-1093.
5. Costelloe C., Metcalfe C., Lovering A., Mant D., Hay A.D. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010, 340:c2096.
6. Arias C.A., Murray B.E. Antibiotic-resistant bugs in the 21st century - a clinical super-challenge. N. Engl. J. Med. 2009, 360:439-443.
7. Galdiero S., Falanga A., Vitiello M., Cantisani M., Marra V., Galdiero M. Silver nanoparticles as potential antiviral agents. Molecules 2011, 16:8894-8918.
8. Simoncic B., Tomsic B. Structures of novel antimicrobial agents for textiles - a review. Text. Res. J. 2010, 80:1721-1737.
9. Chaloupka K., Malam Y., Seifalian A.M. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 2010, 28:580-588.
10. Alexander J.W. History of the medical use of silver. Surg. Infect. 2009, 10:289-292.
11. Chen X., Schluesener H.J. Nanosilver a nanoproduct in medical application. Toxicol. Lett. 2008, 176:1-12.
12. Toy L.W., Macera L. Evidence-based review of silver dressing use on chronic wounds. J. Am. Acad. Nurse Pract. 2011, 23:183-192.
13. Teow Y., Asharani P.V., Hande M.P., Valiyaveettil S. Health impact and safety of engineered nanomaterials. Chem. Commun. 2011, 47:7025-7038.
14. Duran N., Marcato P.D., De Conti R., Alves O.L., Costa F.T.M., Brocchi M. Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action. J. Braz. Chem. Soc. 2010, 21:949-959.
15. Sheng Z.Y., Liu Y. Effects of silver nanoparticles on wastewater biofilms. Water Res. 2011, 45:6039-6050.
16. Kora A.J., Arunachalam J. Assessment of antibacterial activity of silver nanoparticles on Pseudomonas aeruginosa and its mechanism of action. World J. Microbiol. Biotechnol. 2011, 27:1209-1216.
17. Fabrega J., Renshaw J.C., Lead J.R. Interactions of silver nanoparticles with Pseudomonas putida biofilms. Environ. Sci. Technol. 2009, 43:9004-9009.
18. Sotiriou G.A., Pratsinis S.E. Antibacterial activity of nanosilver ions and particles. Environ. Sci. Technol. 2010, 44:5649-5654.
19. Xiu Z.M., Zhang Q.B., Puppala H.L., Colvin V.L., Alvarez P.J.J. Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett. 2012, 12:4271-4275.
20. Lara H.H., Garza-Trevino E.N., Ixtepan-Turrent L., Singh D.K. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. J. Nanobiotechnol. 2011, 9:8.
21. Vaidyanathan R., Kalishwaralal K., Gopalram S., Gurunathan S. Nanosilver - the burgeoning therapeutic molecule and its green synthesis. Biotechnol. Adv. 2009, 27:924-937.
22. Wijnhoven S.W.P., Peijnenburg W.J.G.M., Herberts C.A., Hagens W.I., Oomen A.G., Heugens E.H.W., Roszek B., Bisschops J., Gosens I., van De Meent D., Dekkers S., De Jong W.H., van Zijverden M., Sips A.J.A.M., Geertsma R.E. Nano-silver - a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009, 3:109-138.
23. Park M.V.D.Z., Neigh A.M., Vermeulen J.P., de la Fonteyne L.J.J., Verharen H.W., Briede J.J., van Loveren H., de Jong W.H. The effect of particle size on the cytotoxicity inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials 2011, 32:9810-9817.
24. Marambio-Jones C., Hoek E.M.V. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J. Nanopart. Res. 2010, 12:1531-1551.
25. Lansdown A.B.G. Silver in Healthcare. Its Antimicrobial Efficacy and Safety in Use 2010, Royal Society of Chemistry, Cambridge.
26. Johnston H.J., Hutchison G., Christensen F.M., Peters S., Hankin S., Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit. Rev. Toxicol. 2011, 40:328-346.
27. Braydich-Stolle L., Hussain S., Schlager J.J., Hofman M.C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol. Sci. 2005, 88:412-419.
28. Beer C., Foldbjerg R., Hayashi Y., Sutherland D.S., Autrup H. Toxicity of silver nanoparticles - nanoparticle or silver ion?. Toxicol. Lett. 2012, 208:286-292.
29. Hidalgo E., Dominguez C. Study of cytotoxicity mechanisms of silver nitrate in human dermal fibroblasts. Toxicol. Lett. 1998, 98:169-179.
30. S. Chernousova, M. Epple, Silver as antibacterial agent: ion, nanoparticle, metal, Angew. Chem. Int. Ed., in press.
31. Delben J.R.J., Pimentel O.M., Coelho M.B., Candelorio P.D., Furini L.N., Alencar Dos Santos F., de Vicente F.S., Delben A.A.S.T. Synthesis and thermal properties of nanoparticles of bioactive glasses containing silver. J. Therm. Anal. Calorim. 2009, 97:433-436.
32. Díaz M., Barba F., Miranda M., Guitián F., Torrecillas R., Moya J.S. Synthesis antimicrobial activity of a silver-hydroxyapatite nanocomposite. J. Nanomater. 2009, 2009:1-6.
33. Doi Y., Shibutani T., Moriwaki Y., Kajimoto T., Iwayama Y. Sintered carbonate apatites as bioresorbable bone substitutes. J. Biomed. Mater. Res. 1998, 39:603-610.
34. Ewald A., Hösel D., Patel S., Grover L.M., Barralet J.E., Gbureck U. Silver-doped calcium phosphate cements with antimicrobial activity. Acta Biomater. 2011, 7:4064-4070.
35. Rameshbabu N., Sampath Kumar T.S., Prabhakar T.G., Sastry V.S., Murty K.V.G.K., Prasad Rao K. Antibacterial nanosized silver substituted hydroxyapatite: synthesis and characterization. J. Biomed. Mater. Res. A 2007, 80:581-591.
36. Yang L., Ning X., Xiao Q., Chen K., Zhou H. Development and characterization of porous silver-incorporated hydroxyapatite ceramic for separation and elimination of microorganisms. J. Biomed. Mater. Res. B: Appl. Biomater. 2007, 81:50-56.
37. Chen W., Oh S., Ong A.P., Oh N., Liu Y., Courtney H.S., Appleford M., Ong J.L. Antibacterial and osteogenic properties of silver-containing hydroxyapatite coatings produced using a sol gel process. J. Biomed. Mater. Res. A 2007, 82:899-906.
38. Zhao G., Stevens S.E. Multiple parameters for the comprehensive evaluation of the susceptibility of Escherichia coli to the silver ion. Biometals 1998, 11:27-32.
39. Vogelman B., Craig W.A. Kinetics of antimicrobial activity. J. Pediatr. 1986, 108:835-840.
40. Andrews J.M. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 2001, 48:5-16.
41. English D., Andersen B.R. Single step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradient of ficoll-hypaque. J. Immunol. Methods 1974, 5:249-252.
42. Kovtun A., Kozlova D., Ganesan K., Biewald C., Seipold N., Gaengler P., Arnold W.H., Epple M. Chlorhexidine-loaded calcium phosphate nanoparticles for dental maintenance treatment: combination of mineralising and antibacterial effects. RSC Adv. 2012, 2:870-875.
43. Klesing J., Chernousova S., Epple M. Freeze-dried cationic calcium phosphate nanorods as versatile carriers of nucleic acids (DNA, siRNA). J. Mater. Chem. 2012, 22:199-204.
44. Mahl D., Diendorf J., Meyer-Zaika W., Epple M. Possibilities and limitations of different analytical methods for the size determination of a bimodal dispersion of metallic nanoparticles. Colloid Surf. A: Physicochem. Eng. Aspects 2011, 377:386-392.
45. Kittler S., Greulich C., Diendorf J., Köller M., Epple M. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem. Mater. 2010, 22:4548-4554.
46. Liu J., Sonshine D.A., Shervani S., Hurt R.H. Controlled release of biologically active silver from nanosilver surfaces. ACS Nano 2010, 4:6903-6913.
47. Liu L., Hurt R.H. Ion release kinetics and particle persistence in aqueous nano-silver colloids. Environ. Sci. Technol. 2010, 44:2169-2175.
48. Ho C.M., Yau S.K.W., Lok C.N., So M.H., Che C.M. Oxidative dissolution of silver nanoparticles by biologically relevant oxidants: a kinetic and mechanistic study. Chem. Asian J. 2010, 5:285-293.
49. Greulich C., Braun D., Peetsch A., Diendorf J., Siebers B., Epple M., Koller M. The toxic effect of silver ions and silver nanoparticles towards bacteria and human cells occurs in the same concentration range. RSC Adv. 2012, 2:6981-6987.
50. Greulich C., Diendorf J., Geßmann J., Simon T., Habijan T., Eggeler G., Schildhauer T.A., Epple M., Köller M. Cell type-specific responses of peripheral blood mononuclear cells to silver nanoparticles. Acta Biomater. 2011, 7:3505-3514.
51. Greulich C., Kittler S., Epple M., Muhr G., Köller M. Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langenbecks Arch. Surg. 2009, 394:495-502.
52. Amato E., Diaz-Fernandez Y.A., Taglietti A., Pallavicini P., Pasotti L., Cucca L., Milanese C., Grisoli P., Dacarro C., Fernandez-Hechavarria J.M., Necchi V. Synthesis, characterization and antibacterial activity against gram positive and gram negative bacteria of biomimetically coated silver nanoparticles. Langmuir 2011, 27:9165-9173.
53. Nowack B., Krug H.F., Height M. 120 years of nanosilver history: implications for policy makers. Environ. Sci. Technol. 2011, 45:1177-1183.
54. Brett D.W. A discussion of silver as an antimicrobial agent: alleviating the confusion. Ostomy Wound Manage 2006, 52:34-41.